结果页面 10，板块：医疗保健，行业：生物技术，股市 - 报价与价格
包含价格、市值、市盈率和每股收益的所有股票清单
所有国家
所有交流
- {{item.name}}
- 所有交流
- Amsterdam (3)
- Aquis AQSE (1)
- ASX (45)
- Brussels (7)
- BSE (12)
- Canadian Sec (22)
- Cboe CA (3)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (388)
- Hamburg (1)
- Helsinki (3)
- HKSE (45)
- IOB (24)
- Istanbul (1)
- KOSDAQ (69)
- KSE (10)
- MCE (3)
- MCX (1)
- Mexico (26)
- Milan (3)
- Munich (17)
- NSE (7)
- NYSE (5)
- NYSE American (14)
- NZSE (1)
- Oslo (10)
- OTC Markets EXMKT (40)
- OTC Markets OTCPK (107)
- OTC Markets OTCQB (30)
- OTC Markets OTCQX (5)
- Paris (26)
- São Paulo (13)
- Shanghai (46)
- Shenzhen (43)
- Stockholm (58)
- Stuttgart (21)
- Swiss (10)
- Taipei Exchange (53)
- Taiwan (6)
- Tech Market Large (153)
- Tech Market Middle (83)
- Tech Market Small (209)
- Tel Aviv (13)
- Thailand (2)
- Tokyo (37)
- Toronto (8)
- TSXV (16)
- Vienna (11)
- Warsaw (8)
- XETRA (15)
医疗保健 (1741)
- {{item.name}}
- 所有版块
- 医疗保健 (1741)
生物技术 (1741)
市场热力图
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | 预测 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | 预测 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
Samsung Biologics Co.,Ltd.
207940.KS
KR
|
₩1,363,000 1028.84 USD |
-4.15
|
₩63T 47.63B USD | ₩49K 36.96 USD | ₩1,350,000 1019.03 USD | ₩1,432,000 1080.93 USD | ₩63T 47.63B USD | 0 | ₩0 0 USD | ||
Alnylam Pharmaceuticals, Inc.
A1LN34.SA
BR
|
R$82.80 16.78 USD |
+2.27
|
R$221.10B 44.81B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$221.10B 44.81B USD | 79.61 | R$1.04 0.21 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.F
DE
|
€280.30 323.56 USD |
-0.25
|
€37.42B 43.2B USD | €81.00 93.5 USD | €280.30 323.56 USD | €280.30 323.56 USD | €37.42B 43.2B USD | 80.54 | €3.48 4.02 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.DE
DE
|
€279.80 322.98 USD |
0
|
€37.36B 43.12B USD | €38.00 43.86 USD | €277.60 320.44 USD | €279.80 322.98 USD | €37.36B 43.12B USD | 79.94 | €3.50 4.04 USD | ||
CSL
CMXHF
US
|
$86.38 — |
-0.48
|
$41.37B — | $200.00 — | $77.86 — | $77.89 — | $41.37B — | 13.99 | $6.17 — | ||
CSL Limited
CSJ.F
DE
|
€74.51 86.01 USD |
-0.21
|
€35.68B 41.19B USD | €100.00 115.43 USD | €74.51 86.01 USD | €74.51 86.01 USD | €35.68B 41.19B USD | 13.74 | €5.42 6.26 USD | ||
Revolution Medicines, Inc.
42Z.F
DE
|
€167.15 192.95 USD |
+1.33
|
€35.54B 41.02B USD | €7.00 8.08 USD | €165.50 191.04 USD | €167.95 193.87 USD | €35.54B 41.02B USD | 0 | -€6.25 -7.2 USD | ||
CSL Limited
CSJA.F
DE
|
€17.80 20.55 USD |
-0.56
|
€34.10B 39.36B USD | €100.00 115.43 USD | €17.80 20.55 USD | €17.80 20.55 USD | €34.10B 39.36B USD | 13.08 | €1.36 1.57 USD | ||
Royalty Pharma plc
RPD.MU
DE
|
€50.42 58.2 USD |
0
|
€29.03B 33.51B USD | €0.00 0 USD | €50.42 58.2 USD | €50.42 58.2 USD | €29.03B 33.51B USD | 30.19 | €1.67 1.93 USD | ||
Royalty Pharma plc
RPD.F
DE
|
€49.96 57.67 USD |
+1.18
|
€28.77B 33.21B USD | €40.00 46.17 USD | €49.96 57.67 USD | €49.96 57.67 USD | €28.77B 33.21B USD | 29.91 | €1.67 1.93 USD | ||
Moderna, Inc.
MRNA.MX
MX
|
MX$1,397.14 82.73 USD |
-1.98
|
MX$554.37B 32.83B USD | MX$493.00 29.19 USD | MX$1,389.00 82.25 USD | MX$1,400.00 82.9 USD | MX$554.37B 32.83B USD | 0 | -MX$139.80 -8.2 USD | ||
Moderna, Inc.
0QF.MU
DE
|
€69.93 80.72 USD |
-1.91
|
€27.75B 32.03B USD | €0.00 0 USD | €69.93 80.72 USD | €69.93 80.72 USD | €27.75B 32.03B USD | 0 | -€7.15 -8.2 USD | ||
Moderna, Inc.
0QF.F
DE
|
€68.05 78.55 USD |
-2.28
|
€27.00B 31.17B USD | €851.00 982.34 USD | €64.67 74.65 USD | €70.12 80.94 USD | €27.00B 31.17B USD | 0 | -€7.15 -8.2 USD | ||
Moderna, Inc.
MRNA.VI
AT
|
€67.47 77.88 USD |
-2.43
|
€26.77B 30.9B USD | €1.69K 1.95K USD | €66.62 76.9 USD | €69.70 80.46 USD | €26.77B 30.9B USD | 0 | -€7.15 -8.2 USD | ||
|
BeOne Medicines AG
49BA.F
DE
|
€256.00 295.51 USD |
-3.03
|
€26.56B 30.66B USD | €5.00 5.77 USD | €256.00 295.51 USD | €256.00 295.51 USD | €26.56B 30.66B USD | 65.97 | €3.88 4.48 USD | ||
Celltrion, Inc.
068270.KS
KR
|
₩176,800 133.46 USD |
-0.79
|
₩41T 30.6B USD | ₩792K 598.11 USD | ₩174,700 131.87 USD | ₩183,900 138.81 USD | ₩41T 30.6B USD | 0 | ₩0 0 USD | ||
|
Royalty Pharma plc
RPRXN.MX
MX
|
MX$775.06 45.89 USD |
0
|
MX$446.30B 26.43B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$446.30B 26.43B USD | 23.69 | MX$32.71 1.94 USD | ||
|
Roivant Sciences Ltd.
87S.F
DE
|
€31.25 36.07 USD |
+0.51
|
€22.48B 25.95B USD | €350.00 404.02 USD | €31.25 36.07 USD | €31.32 36.15 USD | €22.48B 25.95B USD | 0 | -€0.48 -0.5 USD | ||
BioNTech SE
0A3M.IL
GB
|
$92.39 — |
-1.45
|
$25.41B — | $36.00 — | $92.39 — | $94.47 — | $25.41B — | 5.13 | $18.00 — | ||
|
BioNTech SE
B1NT34.SA
BR
|
R$30.55 6.19 USD |
+0.63
|
R$124.85B 25.3B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$124.85B 25.3B USD | 0 | -R$1.87 -0.3 USD | ||
|
Insmed Incorporated
IM8N.F
DE
|
€98.61 113.83 USD |
+0.83
|
€21.37B 24.67B USD | €50.00 57.72 USD | €98.61 113.83 USD | €98.61 113.83 USD | €21.37B 24.67B USD | 0 | -€5.06 -5.8 USD | ||
|
Insmed Incorporated
IM8N.SG
DE
|
€97.10 112.09 USD |
-1.45
|
€21.05B 24.29B USD | €0.00 0 USD | €97.00 111.97 USD | €98.09 113.23 USD | €21.05B 24.29B USD | 0 | -€5.05 -5.8 USD | ||
|
Incyte Corporation
I1NC34.SA
BR
|
R$296.96 60.19 USD |
0
|
R$118.65B 24.05B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$118.65B 24.05B USD | 16.18 | R$18.35 3.72 USD | ||
|
BioNTech SE
BNTXN.MX
MX
|
MX$1,590.00 94.15 USD |
0
|
MX$402.09B 23.81B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$402.09B 23.81B USD | 0 | -MX$101.12 -5.9 USD | ||
|
BioNTech SE
BNTX.VI
AT
|
€81.15 93.67 USD |
-0.98
|
€20.52B 23.69B USD | €0.00 0 USD | €81.05 93.56 USD | €81.95 94.6 USD | €20.52B 23.69B USD | 0 | -€5.07 -5.8 USD | ||
BioNTech SE
22UA.F
DE
|
€80.65 93.1 USD |
-1.65
|
€20.40B 23.54B USD | €65.00 75.03 USD | €80.40 92.81 USD | €81.10 93.62 USD | €20.40B 23.54B USD | 0 | -€5.07 -5.8 USD | ||
|
Incyte Corporation
ICY.F
DE
|
€102.00 117.74 USD |
+2.02
|
€20.38B 23.52B USD | €64.00 73.88 USD | €102.00 117.74 USD | €102.70 118.55 USD | €20.38B 23.52B USD | 16.39 | €6.22 7.18 USD | ||
|
Genmab A/S
0MGB.IL
GB
|
DKK 1,888.00 276.82 USD |
-0.57
|
DKK 151.19B 22.17B USD | DKK 2.23K 326.23 USD | DKK 1,874.50 274.84 USD | DKK 1,895.50 277.92 USD | DKK 151.19B 22.17B USD | 26.67 | DKK 70.77 10.38 USD | ||
|
Incyte Corporation
INCY.MX
MX
|
MX$1,676.03 99.24 USD |
0
|
MX$334.84B 19.83B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$334.84B 19.83B USD | 13.51 | MX$124.03 7.34 USD | ||
WuXi Biologics (Cayman)
WXIBF
US
|
$4.76 — |
+1.82
|
$19.57B — | $250.00 — | $4.40 — | $4.40 — | $19.57B — | 28.02 | $0.17 — | ||
Innovent Biologics, Inc.
6IB.F
DE
|
€9.44 10.9 USD |
-1.76
|
€16.37B 18.9B USD | €726.00 838.05 USD | €9.44 10.9 USD | €9.45 10.91 USD | €16.37B 18.9B USD | 157.33 | €0.06 0.07 USD | ||
|
WuXi Biologics (Cayman) Inc.
1FW2.F
DE
|
€3.96 4.57 USD |
-2.94
|
€16.26B 18.77B USD | €2.50K 2.89K USD | €3.96 4.57 USD | €3.96 4.57 USD | €16.26B 18.77B USD | 26.39 | €0.15 0.17 USD | ||
|
WuXi Biologics (Cayman) Inc.
1FW1.F
DE
|
€7.80 9 USD |
-3.11
|
€16.01B 18.49B USD | €134.00 154.68 USD | €7.80 9 USD | €7.80 9 USD | €16.01B 18.49B USD | 26.00 | €0.30 0.35 USD | ||
Genmab A/S
GE91.F
DE
|
€25.20 29.09 USD |
+4.13
|
€15.47B 17.86B USD | €600.00 692.6 USD | €25.20 29.09 USD | €25.20 29.09 USD | €15.47B 17.86B USD | 21.91 | €1.15 1.33 USD | ||
|
GENMAB AS N
GE9.DE
DE
|
€251.60 290.43 USD |
-0.55
|
€15.45B 17.83B USD | €8.00 9.23 USD | €251.60 290.43 USD | €251.60 290.43 USD | €15.45B 17.83B USD | 21.80 | €11.54 13.32 USD | ||
Genmab A/S
GNMSF
US
|
$282.16 — |
0
|
$17.32B — | $140.00 — | $275.00 — | $275.00 — | $17.32B — | 21.45 | $13.15 — | ||
Jazz Pharmaceuticals plc
J7Z.F
DE
|
€214.00 247.03 USD |
-1.2
|
€13.44B 15.52B USD | €50.00 57.72 USD | €214.00 247.03 USD | €214.00 247.03 USD | €13.44B 15.52B USD | 2377.77 | €0.09 0.1 USD | ||
|
BridgeBio Pharma, Inc.
2CL.F
DE
|
€67.48 77.89 USD |
+1.93
|
€13.22B 15.26B USD | €70.00 80.8 USD | €67.48 77.89 USD | €67.48 77.89 USD | €13.22B 15.26B USD | 0 | -€3.28 -3.7 USD | ||
Ascendis Pharma A/S
A71.F
DE
|
€206.00 237.79 USD |
0
|
€12.65B 14.6B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €12.65B 14.6B USD | 0 | €0.00 0 USD | ||
Exelixis, Inc.
EX9.F
DE
|
€49.45 57.08 USD |
+3.02
|
€12.43B 14.35B USD | €1.59K 1.83K USD | €49.45 57.08 USD | €49.45 57.08 USD | €12.43B 14.35B USD | 18.66 | €2.65 3.06 USD | ||
Verona Pharma plc
I9SA.F
DE
|
€90.20 104.12 USD |
0
|
€12.13B 14.01B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €12.13B 14.01B USD | 0 | €0.00 0 USD | ||
Sino Biopharmaceutical Limited
SBMFF
US
|
$0.78 — |
-6.28
|
$13.83B — | $2.00K — | $0.78 — | $0.78 — | $13.83B — | 38.89 | $0.02 — | ||
|
Axsome Therapeutics, Inc.
19X.F
DE
|
€216.50 249.91 USD |
+0.23
|
€11.14B 12.86B USD | €6.00 6.93 USD | €216.50 249.91 USD | €216.50 249.91 USD | €11.14B 12.86B USD | 0 | -€3.26 -3.7 USD | ||
ALTEOGEN Inc.
196170.KQ
KR
|
₩313,500 236.64 USD |
-7.11
|
₩17T 12.66B USD | ₩453K 341.81 USD | ₩307,500 232.11 USD | ₩336,500 254 USD | ₩17T 12.66B USD | 0 | ₩0 0 USD | ||
|
Madrigal Pharmaceuticals, Inc.
YDO1.F
DE
|
€471.80 544.62 USD |
-1.05
|
€10.88B 12.56B USD | €10.00 11.54 USD | €471.80 544.62 USD | €471.80 544.62 USD | €10.88B 12.56B USD | 0 | -€11.82 -13.6 USD | ||
ABIVAX Société Anonyme
2X1.F
DE
|
€123.90 143.02 USD |
-1.12
|
€10.80B 12.47B USD | €30.00 34.63 USD | €123.90 143.02 USD | €123.90 143.02 USD | €10.80B 12.47B USD | 0 | -€4.60 -5.3 USD | ||
Arrowhead Pharmaceuticals, Inc.
HDP1.F
DE
|
€75.44 87.08 USD |
-1.02
|
€10.63B 12.27B USD | €75.00 86.58 USD | €75.44 87.08 USD | €75.44 87.08 USD | €10.63B 12.27B USD | 0 | -€2.00 -2.3 USD | ||
|
BioMarin Pharmaceutical Inc.
BMRN.VI
AT
|
€52.90 61.06 USD |
+1.3
|
€10.22B 11.8B USD | €3.00 3.46 USD | €52.46 60.56 USD | €52.90 61.06 USD | €10.22B 11.8B USD | 43.36 | €1.22 1.41 USD | ||
|
BioMarin Pharmaceutical Inc.
BM8.F
DE
|
€52.52 60.63 USD |
+3.67
|
€10.15B 11.72B USD | €100.00 115.43 USD | €52.52 60.63 USD | €52.52 60.63 USD | €10.15B 11.72B USD | 43.04 | €1.22 1.41 USD | ||
|
Cytokinetics, Incorporated
KK3A.F
DE
|
€73.74 85.12 USD |
-0.14
|
€10.01B 11.56B USD | €37.00 42.71 USD | €73.74 85.12 USD | €73.74 85.12 USD | €10.01B 11.56B USD | 0 | -€6.02 -6.9 USD | ||
|
Bio-Techne Corporation
T1CH34.SA
BR
|
R$12.09 2.45 USD |
-0.98
|
R$56.51B 11.45B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$56.51B 11.45B USD | 100.75 | R$0.12 0.02 USD | ||
|
Sino Biopharmaceutical
SBHMY
US
|
$12.81 — |
0
|
$11.38B — | $128.00 — | $12.68 — | $12.68 — | $11.38B — | 33.71 | $0.38 — | ||
|
Akeso, Inc.
4RY.F
DE
|
€10.70 12.35 USD |
-1.43
|
€9.85B 11.37B USD | €200.00 230.87 USD | €10.69 12.34 USD | €10.70 12.35 USD | €9.85B 11.37B USD | 0 | -€0.16 -0.1 USD | ||
Ionis Pharmaceuticals, Inc.
IONS.MX
MX
|
MX$1,150.00 68.09 USD |
0
|
MX$190.05B 11.25B USD | MX$0.00 0 USD | MX$1,150.00 68.09 USD | MX$1,150.00 68.09 USD | MX$190.05B 11.25B USD | 0 | -MX$28.98 -1.7 USD | ||
|
Financière de Tubize SA
FTD.SG
DE
|
€216.00 249.34 USD |
0
|
€9.61B 11.1B USD | €0.00 0 USD | €214.00 247.03 USD | €216.40 249.8 USD | €9.61B 11.1B USD | 102.85 | €2.10 2.42 USD | ||
Sino Biopharmaceutical Limited
SMZ1.F
DE
|
€0.54 0.62 USD |
+1.76
|
€9.58B 11.06B USD | €2.50K 2.89K USD | €0.54 0.62 USD | €0.54 0.62 USD | €9.58B 11.06B USD | 26.95 | €0.02 0.02 USD | ||
|
BioMarin Pharmaceutical Inc.
B1MR34.SA
BR
|
R$140.85 28.55 USD |
0
|
R$54.45B 11.04B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$54.45B 11.04B USD | 39.01 | R$3.61 0.73 USD | ||
|
Financière de Tubize SA
FTD.F
DE
|
€214.60 247.72 USD |
-0.92
|
€9.55B 11.03B USD | €100.00 115.43 USD | €214.60 247.72 USD | €214.60 247.72 USD | €9.55B 11.03B USD | 102.19 | €2.10 2.42 USD | ||
Bio-Techne Corporation
TE1.F
DE
|
€61.04 70.46 USD |
+0.33
|
€9.51B 10.98B USD | €13.00 15.01 USD | €61.04 70.46 USD | €61.04 70.46 USD | €9.51B 10.98B USD | 100.06 | €0.61 0.7 USD | ||
|
BioMarin Pharmaceutical Inc.
BMRN.MX
MX
|
MX$959.00 56.78 USD |
0
|
MX$185.36B 10.98B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$185.36B 10.98B USD | 39.36 | MX$24.36 1.44 USD | ||
|
Krystal Biotech, Inc.
4KB.SG
DE
|
€320.50 369.96 USD |
-0.68
|
€9.45B 10.91B USD | €0.00 0 USD | €315.70 364.42 USD | €320.50 369.96 USD | €9.45B 10.91B USD | 48.78 | €6.57 7.58 USD | ||
Krystal Biotech, Inc.
4KB.F
DE
|
€320.00 369.39 USD |
-1.6
|
€9.43B 10.89B USD | €18.00 20.78 USD | €320.00 369.39 USD | €320.00 369.39 USD | €9.43B 10.89B USD | 48.70 | €6.57 7.58 USD | ||
|
Corcept Therapeutics Incorporated
HTD.F
DE
|
€81.32 93.87 USD |
+2.5
|
€8.73B 10.08B USD | €8.00 9.23 USD | €81.32 93.87 USD | €81.32 93.87 USD | €8.73B 10.08B USD | 262.32 | €0.31 0.36 USD | ||
|
Bio-Techne Corporation
TECH.MX
MX
|
MX$1,064.35 63.02 USD |
0
|
MX$169.12B 10.01B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$169.12B 10.01B USD | 0 | MX$0.00 0 USD | ||
Halozyme Therapeutics, Inc.
RV7.F
DE
|
€71.06 82.03 USD |
+0.54
|
€8.43B 9.73B USD | €70.00 80.8 USD | €71.06 82.03 USD | €71.06 82.03 USD | €8.43B 9.73B USD | 28.42 | €2.50 2.89 USD | ||
|
Halozyme Therapeutics, Inc.
HALO.MX
MX
|
MX$1,327.00 78.57 USD |
0
|
MX$157.40B 9.32B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$157.40B 9.32B USD | 26.59 | MX$49.90 2.95 USD | ||
|
Jazz Pharmaceuticals plc
JAZZN.MX
MX
|
MX$2,500.00 148.03 USD |
0
|
MX$157.04B 9.3B USD | MX$0.00 0 USD | MX$2,500.00 148.03 USD | MX$2,500.00 148.03 USD | MX$157.04B 9.3B USD | 0 | -MX$106.00 -6.2 USD | ||
|
TG Therapeutics, Inc.
NKB2.F
DE
|
€51.20 59.1 USD |
+2.4
|
€7.84B 9.05B USD | €20.00 23.09 USD | €50.40 58.18 USD | €51.20 59.1 USD | €7.84B 9.05B USD | 20.39 | €2.51 2.9 USD | ||
|
ALK-Abelló A/S
AKBLF
US
|
$40.65 — |
0
|
$9.01B — | $105.00 — | $31.35 — | $31.35 — | $9.01B — | 46.19 | $0.88 — | ||
ImmunityBio, Inc.
26CA.F
DE
|
€7.43 8.58 USD |
-2.37
|
€7.78B 8.98B USD | €1.00K 1.15K USD | €7.43 8.58 USD | €7.53 8.69 USD | €7.78B 8.98B USD | 0 | -€0.75 -0.8 USD | ||
Vaxcyte, Inc.
5VA.MU
DE
|
€52.50 60.6 USD |
+3.96
|
€7.58B 8.75B USD | €0.00 0 USD | €52.50 60.6 USD | €52.50 60.6 USD | €7.58B 8.75B USD | 0 | -€6.05 -6.9 USD | ||
|
Crinetics Pharmaceuticals, Inc.
6Z4.F
DE
|
€71.60 82.65 USD |
-1.24
|
€7.58B 8.75B USD | €60.00 69.26 USD | €71.60 82.65 USD | €71.60 82.65 USD | €7.58B 8.75B USD | 0 | -€4.52 -5.2 USD | ||
Vaxcyte, Inc.
5VA.F
DE
|
€50.50 58.29 USD |
+6.99
|
€7.29B 8.42B USD | €6.00 6.93 USD | €50.50 58.29 USD | €50.50 58.29 USD | €7.29B 8.42B USD | 0 | -€6.05 -6.9 USD | ||
|
ALK-Abelló A/S
4AJ0.F
DE
|
€32.04 36.98 USD |
-0.31
|
€7.10B 8.2B USD | €3.00 3.46 USD | €32.04 36.98 USD | €32.04 36.98 USD | €7.10B 8.2B USD | 41.61 | €0.77 0.89 USD | ||
Biocon Limited
BIOCON.BO
IN
|
₹396.90 4.8 USD |
-2.46
|
₹646.27B 7.82B USD | ₹116.10K 1.4K USD | ₹395.05 4.78 USD | ₹411.00 4.97 USD | ₹646.27B 7.82B USD | 141.24 | ₹2.81 0.03 USD | ||
|
Rhythm Pharmaceuticals, Inc.
1RV.F
DE
|
€98.50 113.7 USD |
+5.91
|
€6.76B 7.8B USD | €49.00 56.56 USD | €98.50 113.7 USD | €98.50 113.7 USD | €6.76B 7.8B USD | 0 | -€2.75 -3.1 USD | ||
Mirum Pharmaceuticals, Inc.
08D.F
DE
|
€109.55 126.46 USD |
+7.72
|
€6.68B 7.71B USD | €15.00 17.32 USD | €109.55 126.46 USD | €109.80 126.75 USD | €6.68B 7.71B USD | 0 | -€11.93 -13.7 USD | ||
ALK-Abelló A/S
0OIR.IL
GB
|
DKK 241.30 35.38 USD |
+61.46
|
DKK 48.44B 7.1B USD | DKK 5.30K 776.51 USD | DKK 240.00 35.19 USD | DKK 241.30 35.38 USD | DKK 48.44B 7.1B USD | 149.87 | DKK 1.61 0.24 USD | ||
|
Merus N.V.
2GH.F
DE
|
€79.00 91.19 USD |
0
|
€6.11B 7.05B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €6.11B 7.05B USD | 0 | €0.00 0 USD | ||
ABIVAX Société Anonyme
AAVXF
US
|
$80.03 — |
0
|
$6.98B — | $500.00 — | $80.03 — | $90.45 — | $6.98B — | 0 | -$5.25 — | ||
Cidara Therapeutics
CDTX
US
|
$221.38 — |
0
|
$6.96B — | $0.00 — | $0.00 — | $0.00 — | $6.96B — | 0 | $0.00 — | ||
|
Merus
MRUS
US
|
$90.00 — |
0
|
$6.83B — | $0.00 — | $0.00 — | $0.00 — | $6.83B — | 0 | $0.00 — | ||
Scholar Rock Holding Corporation
2QK.F
DE
|
€49.12 56.7 USD |
+2.04
|
€5.89B 6.79B USD | €30.00 34.63 USD | €49.12 56.7 USD | €49.12 56.7 USD | €5.89B 6.79B USD | 0 | -€3.03 -3.4 USD | ||
|
RemeGen Co., Ltd.
REG.F
DE
|
€9.36 10.8 USD |
+4.07
|
€5.64B 6.5B USD | €50.00 57.72 USD | €9.36 10.8 USD | €9.36 10.8 USD | €5.64B 6.5B USD | 55.05 | €0.17 0.2 USD | ||
Ligand Pharmaceuticals Incorporated
LGDN.F
DE
|
€276.00 318.6 USD |
+1.47
|
€5.53B 6.39B USD | €20.00 23.09 USD | €276.00 318.6 USD | €276.00 318.6 USD | €5.53B 6.39B USD | 40.88 | €6.75 7.79 USD | ||
|
Xenon Pharmaceuticals Inc.
XP0.F
DE
|
€55.00 63.49 USD |
+4.76
|
€5.32B 6.14B USD | €43.00 49.64 USD | €55.00 63.49 USD | €55.00 63.49 USD | €5.32B 6.14B USD | 0 | -€4.13 -4.7 USD | ||
|
CRISPR Therapeutics AG
CRSPN.MX
MX
|
MX$1,040.00 61.58 USD |
-4.59
|
MX$102.42B 6.06B USD | MX$1.50K 88.82 USD | MX$1,040.00 61.58 USD | MX$1,045.23 61.89 USD | MX$102.42B 6.06B USD | 0 | -MX$108.12 -6.4 USD | ||
3SBio Inc.
83B.F
DE
|
€1.89 2.18 USD |
-2.97
|
€4.71B 5.44B USD | €1.10K 1.27K USD | €1.89 2.18 USD | €2.04 2.35 USD | €4.71B 5.44B USD | 4.28 | €0.44 0.51 USD | ||
Legend Biotech Corporation
9LB.F
DE
|
€24.00 27.7 USD |
0
|
€4.64B 5.36B USD | €100.00 115.43 USD | €24.00 27.7 USD | €24.00 27.7 USD | €4.64B 5.36B USD | 0 | -€1.21 -1.3 USD | ||
|
Asymchem Laboratories (Tianjin) Co., Ltd.
7K90.F
DE
|
€12.20 14.08 USD |
+1.67
|
€4.40B 5.08B USD | €100.00 115.43 USD | €12.20 14.08 USD | €12.20 14.08 USD | €4.40B 5.08B USD | 30.50 | €0.40 0.46 USD | ||
Apellis Pharmaceuticals Inc
1JK.F
DE
|
€34.11 39.37 USD |
0
|
€4.37B 5.04B USD | €10.00 11.54 USD | €34.11 39.37 USD | €34.11 39.37 USD | €4.37B 5.04B USD | 37.48 | €0.91 1.05 USD | ||
|
HLB Co., Ltd.
028300.KQ
KR
|
₩50,100 37.82 USD |
-3.09
|
₩7T 5.03B USD | ₩723K 545.74 USD | ₩49,400 37.29 USD | ₩51,700 39.03 USD | ₩7T 5.03B USD | 0 | ₩0 0 USD | ||
Viking Therapeutics, Inc.
1VT.F
DE
|
€36.70 42.36 USD |
+10.04
|
€4.26B 4.92B USD | €1.38K 1.59K USD | €34.80 40.17 USD | €36.90 42.59 USD | €4.26B 4.92B USD | 0 | -€3.65 -4.2 USD | ||
SK Biopharmaceuticals Co., Ltd.
326030.KS
KR
|
₩82,100 61.97 USD |
-3.3
|
₩6T 4.85B USD | ₩144K 108.62 USD | ₩80,600 60.84 USD | ₩85,500 64.54 USD | ₩6T 4.85B USD | 0 | ₩0 0 USD | ||
|
Amicus Therapeutics
FOLD
US
|
$14.49 — |
0
|
$4.55B — | $0.00 — | $0.00 — | $0.00 — | $4.55B — | 0 | $0.00 — | ||
|
Akero Therapeutics
AKRO
US
|
$54.65 — |
0
|
$4.50B — | $0.00 — | $0.00 — | $0.00 — | $4.50B — | 0 | $0.00 — | ||
|
ACADIA Pharmaceuticals Inc.
DR6.F
DE
|
€22.74 26.25 USD |
+1.93
|
€3.89B 4.49B USD | €20.00 23.09 USD | €22.74 26.25 USD | €22.74 26.25 USD | €3.89B 4.49B USD | 11.72 | €1.94 2.24 USD | ||
|
Akero Therapeutics, Inc.
0K4.F
DE
|
€46.53 53.71 USD |
0
|
€3.85B 4.44B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €3.85B 4.44B USD | 0 | €0.00 0 USD | ||
|
Agios Pharmaceuticals, Inc.
AGIO.MX
MX
|
MX$1,222.00 72.36 USD |
0
|
MX$72.67B 4.3B USD | MX$0.00 0 USD | MX$1,222.00 72.36 USD | MX$1,222.00 72.36 USD | MX$72.67B 4.3B USD | 5.16 | MX$236.58 14.01 USD | ||
|
BB Biotech AG
BBAGF
US
|
$76.06 — |
0
|
$4.19B — | $100.00 — | $33.65 — | $33.65 — | $4.19B — | 5.66 | $13.42 — | ||
|
没有最喜欢的股票
您还没有喜欢的股票，请将其添加到收藏夹以在此处查看 |
|||||||||||